Staar Promotes Visian ICL For Myopia As Cataract Sales Decline
This article was originally published in The Gray Sheet
Executive Summary
A successful rollout of Staar Surgical's recently FDA-approved Visian implantable contact lens (ICL) nearly offset steadily declining sales of its cataract products during the first quarter